Back
Speaker illustration

Ms Janvi Sah

Ann Arbor (United States of America)

Presentations

Effectiveness and safety of apixaban vs warfarin among older venous thromboembolism patients: a subgroup analysis of age

Event: ESC Congress 2021 - The Digital Experience

Topic: Venous Thromboembolism

Session: Pulmonary circulation, pulmonary embolism, right heart failure e-posters

Access
0
Thumbnail

Effectiveness and safety of apixaban vs warfarin among older venous thromboembolism patients stratified by race

Event: ESC Congress 2021 - The Digital Experience

Topic: Venous Thromboembolism

Session: Pulmonary circulation, pulmonary embolism, right heart failure e-posters

Access
0
Thumbnail

Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients using five US databases: a subgroup analysis of chronic liver disease

Event: ESC Congress 2021 - The Digital Experience

Topic: Venous Thromboembolism

Session: Pulmonary circulation, pulmonary embolism, right heart failure e-posters

Access
0
Thumbnail

ESC 365 is supported by

logo Novo Nordisk